#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=2. Follicular Ovarian Reserve and Its Regulation
1-1	0-2	2.	_	_	_	_
1-2	3-13	Follicular	abstract[2]	new[2]	ana	1-6[0_2]
1-3	14-21	Ovarian	person|abstract[2]	new|new[2]	coref	2-6
1-4	22-29	Reserve	abstract[2]	new[2]	_	_
1-5	30-33	and	_	_	_	_
1-6	34-37	Its	abstract|abstract[4]	giv|new[4]	coref	18-12[157_4]
1-7	38-48	Regulation	abstract[4]	new[4]	_	_

#Text=In mammals , the follicular ovarian reserve , constituted by primordial follicles , is established early on in life then keeps declining regularly throughout the reproductive period .
2-1	49-51	In	_	_	_	_
2-2	52-59	mammals	animal	new	_	_
2-3	60-61	,	_	_	_	_
2-4	62-65	the	place[7]	new[7]	coref	18-15[159_7]
2-5	66-76	follicular	place[7]	new[7]	_	_
2-6	77-84	ovarian	person|place[7]	giv|new[7]	coref	18-16
2-7	85-92	reserve	place[7]	new[7]	_	_
2-8	93-94	,	_	_	_	_
2-9	95-106	constituted	_	_	_	_
2-10	107-109	by	_	_	_	_
2-11	110-120	primordial	object[8]	new[8]	coref	3-4[12_8]
2-12	121-130	follicles	object[8]	new[8]	_	_
2-13	131-132	,	_	_	_	_
2-14	133-135	is	_	_	_	_
2-15	136-147	established	_	_	_	_
2-16	148-153	early	_	_	_	_
2-17	154-156	on	_	_	_	_
2-18	157-159	in	_	_	_	_
2-19	160-164	life	abstract	new	coref	2-25[10_0]
2-20	165-169	then	_	_	_	_
2-21	170-175	keeps	_	_	_	_
2-22	176-185	declining	_	_	_	_
2-23	186-195	regularly	_	_	_	_
2-24	196-206	throughout	_	_	_	_
2-25	207-210	the	abstract[10]	giv[10]	coref	3-17[15_10]
2-26	211-223	reproductive	abstract[10]	giv[10]	_	_
2-27	224-230	period	abstract[10]	giv[10]	_	_
2-28	231-232	.	_	_	_	_

#Text=The pool of primordial follicles serves as a source of growing follicles and fertilizable eggs for the entire female reproductive life .
3-1	233-236	The	place[11]	new[11]	coref	19-9[163_11]
3-2	237-241	pool	place[11]	new[11]	_	_
3-3	242-244	of	place[11]	new[11]	_	_
3-4	245-255	primordial	place[11]|object[12]	new[11]|giv[12]	coref	3-12[13_12]
3-5	256-265	follicles	place[11]|object[12]	new[11]|giv[12]	_	_
3-6	266-272	serves	_	_	_	_
3-7	273-275	as	_	_	_	_
3-8	276-277	a	_	_	_	_
3-9	278-284	source	_	_	_	_
3-10	285-287	of	_	_	_	_
3-11	288-295	growing	_	_	_	_
3-12	296-305	follicles	object[13]	giv[13]	coref	5-6[21_13]
3-13	306-309	and	object[13]	giv[13]	_	_
3-14	310-322	fertilizable	object[13]|object[14]	giv[13]|new[14]	_	_
3-15	323-327	eggs	object[13]|object[14]	giv[13]|new[14]	_	_
3-16	328-331	for	object[13]|object[14]	giv[13]|new[14]	_	_
3-17	332-335	the	object[13]|object[14]|abstract[15]	giv[13]|new[14]|giv[15]	coref	8-6[42_15]
3-18	336-342	entire	object[13]|object[14]|abstract[15]	giv[13]|new[14]|giv[15]	_	_
3-19	343-349	female	object[13]|object[14]|abstract[15]	giv[13]|new[14]|giv[15]	_	_
3-20	350-362	reproductive	object[13]|object[14]|abstract[15]	giv[13]|new[14]|giv[15]	_	_
3-21	363-367	life	object[13]|object[14]|abstract[15]	giv[13]|new[14]|giv[15]	_	_
3-22	368-369	.	_	_	_	_

#Text=Actually , each primordial follicle can remain quiescent for years ; be activated and enter the growing process ; or undergo atresia directly from the dormant stage .
4-1	370-378	Actually	_	_	_	_
4-2	379-380	,	_	_	_	_
4-3	381-385	each	animal[16]	new[16]	coref	7-23[0_16]
4-4	386-396	primordial	animal[16]	new[16]	_	_
4-5	397-405	follicle	animal[16]	new[16]	_	_
4-6	406-409	can	_	_	_	_
4-7	410-416	remain	_	_	_	_
4-8	417-426	quiescent	_	_	_	_
4-9	427-430	for	_	_	_	_
4-10	431-436	years	_	_	_	_
4-11	437-438	;	_	_	_	_
4-12	439-441	be	_	_	_	_
4-13	442-451	activated	_	_	_	_
4-14	452-455	and	_	_	_	_
4-15	456-461	enter	_	_	_	_
4-16	462-465	the	event[17]	new[17]	coref	18-8[156_17]
4-17	466-473	growing	event[17]	new[17]	_	_
4-18	474-481	process	event[17]	new[17]	_	_
4-19	482-483	;	_	_	_	_
4-20	484-486	or	_	_	_	_
4-21	487-494	undergo	_	_	_	_
4-22	495-502	atresia	abstract	new	_	_
4-23	503-511	directly	_	_	_	_
4-24	512-516	from	_	_	_	_
4-25	517-520	the	abstract[19]	new[19]	coref	6-2[24_19]
4-26	521-528	dormant	abstract[19]	new[19]	_	_
4-27	529-534	stage	abstract[19]	new[19]	_	_
4-28	535-536	.	_	_	_	_

#Text=To produce mature oocytes , activated primordial follicles develop through primary and secondary stages before acquiring an antral cavity .
5-1	537-539	To	_	_	_	_
5-2	540-547	produce	_	_	_	_
5-3	548-554	mature	object[20]	new[20]	coref	10-19[61_20]
5-4	555-562	oocytes	object[20]	new[20]	_	_
5-5	563-564	,	_	_	_	_
5-6	565-574	activated	object[21]	giv[21]	coref	6-6[25_21]
5-7	575-585	primordial	object[21]	giv[21]	_	_
5-8	586-595	follicles	object[21]	giv[21]	_	_
5-9	596-603	develop	_	_	_	_
5-10	604-611	through	_	_	_	_
5-11	612-619	primary	abstract[22]	new[22]	_	_
5-12	620-623	and	abstract[22]	new[22]	_	_
5-13	624-633	secondary	abstract[22]	new[22]	_	_
5-14	634-640	stages	abstract[22]	new[22]	_	_
5-15	641-647	before	_	_	_	_
5-16	648-657	acquiring	_	_	_	_
5-17	658-660	an	place[23]	new[23]	_	_
5-18	661-667	antral	place[23]	new[23]	_	_
5-19	668-674	cavity	place[23]	new[23]	_	_
5-20	675-676	.	_	_	_	_

#Text=At the antral stage , most follicles undergo apoptotic degeneration and only a few of them grow further to reach the preovulatory stage under the cyclic gonadotropin stimulation that occurs after puberty .
6-1	677-679	At	_	_	_	_
6-2	680-683	the	abstract[24]	giv[24]	coref	6-21[28_24]
6-3	684-690	antral	abstract[24]	giv[24]	_	_
6-4	691-696	stage	abstract[24]	giv[24]	_	_
6-5	697-698	,	_	_	_	_
6-6	699-703	most	object[25]	giv[25]	ana	6-16[0_25]
6-7	704-713	follicles	object[25]	giv[25]	_	_
6-8	714-721	undergo	_	_	_	_
6-9	722-731	apoptotic	abstract[26]	new[26]	_	_
6-10	732-744	degeneration	abstract[26]	new[26]	_	_
6-11	745-748	and	_	_	_	_
6-12	749-753	only	_	_	_	_
6-13	754-755	a	_	_	_	_
6-14	756-759	few	_	_	_	_
6-15	760-762	of	_	_	_	_
6-16	763-767	them	object	giv	coref	7-15[36_0]
6-17	768-772	grow	_	_	_	_
6-18	773-780	further	_	_	_	_
6-19	781-783	to	_	_	_	_
6-20	784-789	reach	_	_	_	_
6-21	790-793	the	abstract[28]	giv[28]	_	_
6-22	794-806	preovulatory	abstract[28]	giv[28]	_	_
6-23	807-812	stage	abstract[28]	giv[28]	_	_
6-24	813-818	under	_	_	_	_
6-25	819-822	the	abstract[30]	new[30]	_	_
6-26	823-829	cyclic	abstract[30]	new[30]	_	_
6-27	830-842	gonadotropin	person|abstract[30]	new|new[30]	_	_
6-28	843-854	stimulation	abstract[30]	new[30]	_	_
6-29	855-859	that	_	_	_	_
6-30	860-866	occurs	_	_	_	_
6-31	867-872	after	_	_	_	_
6-32	873-880	puberty	event	new	_	_
6-33	881-882	.	_	_	_	_

#Text=The maintenance of female reproductive function implies the presence of a vast majority of quiescent primordial follicles and continuous repression of primordial follicle activation into early growing follicles .
7-1	883-886	The	abstract[32]	new[32]	_	_
7-2	887-898	maintenance	abstract[32]	new[32]	_	_
7-3	899-901	of	abstract[32]	new[32]	_	_
7-4	902-908	female	abstract[32]|abstract[33]	new[32]|new[33]	_	_
7-5	909-921	reproductive	abstract[32]|abstract[33]	new[32]|new[33]	_	_
7-6	922-930	function	abstract[32]|abstract[33]	new[32]|new[33]	_	_
7-7	931-938	implies	_	_	_	_
7-8	939-942	the	abstract[34]	new[34]	_	_
7-9	943-951	presence	abstract[34]	new[34]	_	_
7-10	952-954	of	abstract[34]	new[34]	_	_
7-11	955-956	a	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-12	957-961	vast	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-13	962-970	majority	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-14	971-973	of	abstract[34]|abstract[35]	new[34]|new[35]	_	_
7-15	974-983	quiescent	abstract[34]|abstract[35]|object[36]	new[34]|new[35]|giv[36]	coref	11-4[66_36]
7-16	984-994	primordial	abstract[34]|abstract[35]|object[36]	new[34]|new[35]|giv[36]	_	_
7-17	995-1004	follicles	abstract[34]|abstract[35]|object[36]	new[34]|new[35]|giv[36]	_	_
7-18	1005-1008	and	abstract[34]|abstract[35]|object[36]	new[34]|new[35]|giv[36]	_	_
7-19	1009-1019	continuous	abstract[34]|abstract[35]|object[36]|event[37]	new[34]|new[35]|giv[36]|new[37]	_	_
7-20	1020-1030	repression	abstract[34]|abstract[35]|object[36]|event[37]	new[34]|new[35]|giv[36]|new[37]	_	_
7-21	1031-1033	of	abstract[34]|abstract[35]|object[36]|event[37]	new[34]|new[35]|giv[36]|new[37]	_	_
7-22	1034-1044	primordial	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	coref	8-1[40_39]
7-23	1045-1053	follicle	abstract[34]|abstract[35]|object[36]|event[37]|animal|event[39]	new[34]|new[35]|giv[36]|new[37]|giv|new[39]	coref	14-31
7-24	1054-1064	activation	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	_	_
7-25	1065-1069	into	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	_	_
7-26	1070-1075	early	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	_	_
7-27	1076-1083	growing	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	_	_
7-28	1084-1093	follicles	abstract[34]|abstract[35]|object[36]|event[37]|event[39]	new[34]|new[35]|giv[36]|new[37]|new[39]	_	_
7-29	1094-1095	.	_	_	_	_

#Text=This activation , starting during fetal life , is finely controlled though maintaining a balance between inhibitory and stimulatory factors .
8-1	1096-1100	This	event[40]	giv[40]	coref	9-21[56_40]
8-2	1101-1111	activation	event[40]	giv[40]	_	_
8-3	1112-1113	,	_	_	_	_
8-4	1114-1122	starting	_	_	_	_
8-5	1123-1129	during	_	_	_	_
8-6	1130-1135	fetal	substance|time[42]	new|giv[42]	coref	17-2[147_42]
8-7	1136-1140	life	time[42]	giv[42]	_	_
8-8	1141-1142	,	_	_	_	_
8-9	1143-1145	is	_	_	_	_
8-10	1146-1152	finely	_	_	_	_
8-11	1153-1163	controlled	_	_	_	_
8-12	1164-1170	though	_	_	_	_
8-13	1171-1182	maintaining	_	_	_	_
8-14	1183-1184	a	abstract[43]	new[43]	coref	20-13[178_43]
8-15	1185-1192	balance	abstract[43]	new[43]	_	_
8-16	1193-1200	between	abstract[43]	new[43]	_	_
8-17	1201-1211	inhibitory	abstract[43]|abstract|abstract[45]|abstract[47]	new[43]|new|new[45]|new[47]	coref|coref|coref	10-1[57_47]|22-14[193_0]|22-14[194_45]
8-18	1212-1215	and	abstract[43]|abstract[45]|abstract[47]	new[43]|new[45]|new[47]	_	_
8-19	1216-1227	stimulatory	abstract[43]|abstract[45]|abstract|abstract[47]	new[43]|new[45]|new|new[47]	_	_
8-20	1228-1235	factors	abstract[43]|abstract[47]	new[43]|new[47]	_	_
8-21	1236-1237	.	_	_	_	_

#Text=In vitro experiments and genetically modified mouse or sheep models have enabled the decoding of the molecular mechanisms that control follicular activation .
9-1	1238-1240	In	_	_	_	_
9-2	1241-1246	vitro	organization|event[49]	new|new[49]	_	_
9-3	1247-1258	experiments	event[49]	new[49]	_	_
9-4	1259-1262	and	_	_	_	_
9-5	1263-1274	genetically	animal[50]	new[50]	coref	13-6[0_50]
9-6	1275-1283	modified	animal[50]	new[50]	_	_
9-7	1284-1289	mouse	animal[50]	new[50]	_	_
9-8	1290-1292	or	_	_	_	_
9-9	1293-1298	sheep	animal|abstract[52]	new|new[52]	coref	13-4[99_52]
9-10	1299-1305	models	abstract[52]	new[52]	_	_
9-11	1306-1310	have	_	_	_	_
9-12	1311-1318	enabled	_	_	_	_
9-13	1319-1322	the	abstract[53]	new[53]	_	_
9-14	1323-1331	decoding	abstract[53]	new[53]	_	_
9-15	1332-1334	of	abstract[53]	new[53]	_	_
9-16	1335-1338	the	abstract[53]|abstract[54]	new[53]|new[54]	coref	17-14[150_54]
9-17	1339-1348	molecular	abstract[53]|abstract[54]	new[53]|new[54]	_	_
9-18	1349-1359	mechanisms	abstract[53]|abstract[54]	new[53]|new[54]	_	_
9-19	1360-1364	that	_	_	_	_
9-20	1365-1372	control	abstract	new	coref|none	13-30[107_0]|9-20[0_107]
9-21	1373-1383	follicular	abstract|event[56]	new|giv[56]	coref|coref	12-20[97_56]|14-36
9-22	1384-1394	activation	event[56]	giv[56]	_	_
9-23	1395-1396	.	_	_	_	_

#Text=Numerous factors , such as growth factors , hormones , transcription factors , or cytokines , produced by oocytes and/or granulosa cells , can act in an autocrine , paracrine , or endocrine manner .
10-1	1397-1405	Numerous	abstract[57]	giv[57]	coref	20-24[182_57]
10-2	1406-1413	factors	abstract[57]	giv[57]	_	_
10-3	1414-1415	,	abstract[57]	giv[57]	_	_
10-4	1416-1420	such	abstract[57]	giv[57]	_	_
10-5	1421-1423	as	abstract[57]	giv[57]	_	_
10-6	1424-1430	growth	abstract[57]|abstract	giv[57]|new	_	_
10-7	1431-1438	factors	abstract[57]	giv[57]	_	_
10-8	1439-1440	,	abstract[57]	giv[57]	_	_
10-9	1441-1449	hormones	abstract[57]|substance	giv[57]|new	_	_
10-10	1450-1451	,	abstract[57]	giv[57]	_	_
10-11	1452-1465	transcription	abstract[57]	giv[57]	_	_
10-12	1466-1473	factors	abstract[57]	giv[57]	_	_
10-13	1474-1475	,	abstract[57]	giv[57]	_	_
10-14	1476-1478	or	abstract[57]	giv[57]	_	_
10-15	1479-1488	cytokines	abstract[57]|abstract	giv[57]|new	_	_
10-16	1489-1490	,	_	_	_	_
10-17	1491-1499	produced	_	_	_	_
10-18	1500-1502	by	_	_	_	_
10-19	1503-1510	oocytes	object[61]	giv[61]	coref	12-17[0_61]
10-20	1511-1517	and/or	object[61]	giv[61]	_	_
10-21	1518-1527	granulosa	object[61]|object[62]	giv[61]|new[62]	_	_
10-22	1528-1533	cells	object[61]|object[62]	giv[61]|new[62]	_	_
10-23	1534-1535	,	_	_	_	_
10-24	1536-1539	can	_	_	_	_
10-25	1540-1543	act	_	_	_	_
10-26	1544-1546	in	_	_	_	_
10-27	1547-1549	an	abstract[63]	new[63]	_	_
10-28	1550-1559	autocrine	abstract[63]	new[63]	_	_
10-29	1560-1561	,	_	_	_	_
10-30	1562-1571	paracrine	_	_	_	_
10-31	1572-1573	,	_	_	_	_
10-32	1574-1576	or	_	_	_	_
10-33	1577-1586	endocrine	abstract[64]	new[64]	coref	20-2[172_64]
10-34	1587-1593	manner	abstract[64]	new[64]	_	_
10-35	1594-1595	.	_	_	_	_

#Text=The quiescence of primordial follicles is maintained by several molecules including phosphatase and tensin homolog deleted on chromosome 10 ( Pten ) , tuberous sclerosis complexes 1 – 2 ( Tsc1 – Tsc2 ) complex , Forkhead box protein O3A ( Foxo3A ) , p27 , anti-Müllerian hormone ( AMH ) , and Forkhead box L2 ( FoxL2 ) .
11-1	1596-1599	The	abstract[65]	new[65]	_	_
11-2	1600-1610	quiescence	abstract[65]	new[65]	_	_
11-3	1611-1613	of	abstract[65]	new[65]	_	_
11-4	1614-1624	primordial	abstract[65]|object[66]	new[65]|giv[66]	coref	13-37[111_66]
11-5	1625-1634	follicles	abstract[65]|object[66]	new[65]|giv[66]	_	_
11-6	1635-1637	is	_	_	_	_
11-7	1638-1648	maintained	_	_	_	_
11-8	1649-1651	by	_	_	_	_
11-9	1652-1659	several	substance[67]	new[67]	coref	22-17[195_67]
11-10	1660-1669	molecules	substance[67]	new[67]	_	_
11-11	1670-1679	including	substance[67]	new[67]	_	_
11-12	1680-1691	phosphatase	substance[67]|substance	new[67]|new	_	_
11-13	1692-1695	and	substance[67]	new[67]	_	_
11-14	1696-1702	tensin	substance[67]|person|object[70]	new[67]|new|new[70]	_	_
11-15	1703-1710	homolog	substance[67]|object[70]	new[67]|new[70]	_	_
11-16	1711-1718	deleted	_	_	_	_
11-17	1719-1721	on	_	_	_	_
11-18	1722-1732	chromosome	place[71]	new[71]	_	_
11-19	1733-1735	10	place[71]	new[71]	_	_
11-20	1736-1737	(	place[71]	new[71]	_	_
11-21	1738-1742	Pten	place[71]|animal	new[71]|new	coref	14-4
11-22	1743-1744	)	place[71]	new[71]	_	_
11-23	1745-1746	,	_	_	_	_
11-24	1747-1755	tuberous	abstract[74]	new[74]	appos	11-31[76_74]
11-25	1756-1765	sclerosis	place|abstract[74]	new|new[74]	_	_
11-26	1766-1775	complexes	abstract[74]	new[74]	_	_
11-27	1776-1777	1	abstract[74]	new[74]	_	_
11-28	1778-1779	–	abstract[74]	new[74]	_	_
11-29	1780-1781	2	abstract[74]|quantity	new[74]|new	coref	14-8
11-30	1782-1783	(	_	_	_	_
11-31	1784-1788	Tsc1	abstract[76]	giv[76]	_	_
11-32	1789-1790	–	abstract[76]	giv[76]	_	_
11-33	1791-1795	Tsc2	abstract[76]|abstract	giv[76]|new	_	_
11-34	1796-1797	)	_	_	_	_
11-35	1798-1805	complex	_	_	_	_
11-36	1806-1807	,	_	_	_	_
11-37	1808-1816	Forkhead	object|object[81]	new|new[81]	appos|coref	11-42[0_81]|11-54
11-38	1817-1820	box	object|object[81]	new|new[81]	coref	11-55
11-39	1821-1828	protein	substance|object[81]	new|new[81]	coref	21-14[188_0]
11-40	1829-1832	O3A	object[81]	new[81]	_	_
11-41	1833-1834	(	_	_	_	_
11-42	1835-1841	Foxo3A	object	giv	_	_
11-43	1842-1843	)	_	_	_	_
11-44	1844-1845	,	_	_	_	_
11-45	1846-1849	p27	abstract	new	_	_
11-46	1850-1851	,	_	_	_	_
11-47	1852-1866	anti-Müllerian	person|substance[85]	new|new[85]	_	_
11-48	1867-1874	hormone	substance[85]	new[85]	_	_
11-49	1875-1876	(	_	_	_	_
11-50	1877-1880	AMH	object	new	_	_
11-51	1881-1882	)	_	_	_	_
11-52	1883-1884	,	_	_	_	_
11-53	1885-1888	and	_	_	_	_
11-54	1889-1897	Forkhead	object|abstract[89]	giv|new[89]	_	_
11-55	1898-1901	box	object|abstract[89]	giv|new[89]	_	_
11-56	1902-1904	L2	abstract[89]	new[89]	_	_
11-57	1905-1906	(	_	_	_	_
11-58	1907-1912	FoxL2	abstract	new	_	_
11-59	1913-1914	)	_	_	_	_
11-60	1915-1916	.	_	_	_	_

#Text=Many studies have highlighted the crucial roles of the phosphatidyl-inositol-3-kinase ( PI3K ) signaling pathway in oocytes in controlling follicular activation .
12-1	1917-1921	Many	abstract[91]	new[91]	coref	18-1[153_91]
12-2	1922-1929	studies	abstract[91]	new[91]	_	_
12-3	1930-1934	have	_	_	_	_
12-4	1935-1946	highlighted	_	_	_	_
12-5	1947-1950	the	abstract[92]	new[92]	_	_
12-6	1951-1958	crucial	abstract[92]	new[92]	_	_
12-7	1959-1964	roles	abstract[92]	new[92]	_	_
12-8	1965-1967	of	abstract[92]	new[92]	_	_
12-9	1968-1971	the	abstract[92]|abstract[93]	new[92]|new[93]	appos	12-12[0_93]
12-10	1972-2002	phosphatidyl-inositol-3-kinase	abstract[92]|abstract[93]	new[92]|new[93]	_	_
12-11	2003-2004	(	abstract[92]	new[92]	_	_
12-12	2005-2009	PI3K	abstract[92]|abstract	new[92]|giv	ana	13-9
12-13	2010-2011	)	abstract[92]	new[92]	_	_
12-14	2012-2021	signaling	abstract[92]|place[95]	new[92]|new[95]	coref	13-26[0_95]
12-15	2022-2029	pathway	abstract[92]|place[95]	new[92]|new[95]	_	_
12-16	2030-2032	in	abstract[92]|place[95]	new[92]|new[95]	_	_
12-17	2033-2040	oocytes	abstract[92]|place[95]|object	new[92]|new[95]|giv	coref	14-27
12-18	2041-2043	in	_	_	_	_
12-19	2044-2055	controlling	_	_	_	_
12-20	2056-2066	follicular	event[97]	giv[97]	coref	13-35[110_97]
12-21	2067-2077	activation	event[97]	giv[97]	_	_
12-22	2078-2079	.	_	_	_	_

#Text=Indeed , in genetically modified mouse models , it was observed that the PI3K – Akt – mammalian target of rapamycin ( mTOR ) signaling pathway is crucial for the control of survival and activation of primordial follicles .
13-1	2080-2086	Indeed	_	_	_	_
13-2	2087-2088	,	_	_	_	_
13-3	2089-2091	in	_	_	_	_
13-4	2092-2103	genetically	abstract[99]	giv[99]	coref	15-2[126_99]
13-5	2104-2112	modified	abstract[99]	giv[99]	_	_
13-6	2113-2118	mouse	animal|abstract[99]	giv|giv[99]	_	_
13-7	2119-2125	models	abstract[99]	giv[99]	_	_
13-8	2126-2127	,	_	_	_	_
13-9	2128-2130	it	abstract	giv	coref	13-13[101_0]
13-10	2131-2134	was	_	_	_	_
13-11	2135-2143	observed	_	_	_	_
13-12	2144-2148	that	_	_	_	_
13-13	2149-2152	the	abstract[101]	giv[101]	appos	13-16[0_101]
13-14	2153-2157	PI3K	abstract[101]	giv[101]	_	_
13-15	2158-2159	–	_	_	_	_
13-16	2160-2163	Akt	abstract	giv	coref	16-19
13-17	2164-2165	–	_	_	_	_
13-18	2166-2175	mammalian	abstract[103]	new[103]	_	_
13-19	2176-2182	target	abstract[103]	new[103]	_	_
13-20	2183-2185	of	abstract[103]	new[103]	_	_
13-21	2186-2195	rapamycin	abstract[103]|abstract	new[103]|new	appos	13-23
13-22	2196-2197	(	_	_	_	_
13-23	2198-2202	mTOR	abstract	giv	coref	15-5
13-24	2203-2204	)	_	_	_	_
13-25	2205-2214	signaling	_	_	_	_
13-26	2215-2222	pathway	place	giv	coref	14-13[117_0]
13-27	2223-2225	is	_	_	_	_
13-28	2226-2233	crucial	_	_	_	_
13-29	2234-2237	for	_	_	_	_
13-30	2238-2241	the	abstract[107]	new[107]	_	_
13-31	2242-2249	control	abstract[107]	new[107]	_	_
13-32	2250-2252	of	abstract[107]	new[107]	_	_
13-33	2253-2261	survival	abstract[107]|event|event[109]	new[107]|new|new[109]	coref	20-2[175_109]
13-34	2262-2265	and	abstract[107]|event[109]	new[107]|new[109]	_	_
13-35	2266-2276	activation	abstract[107]|event[109]|event[110]	new[107]|new[109]|giv[110]	coref	14-30[123_110]
13-36	2277-2279	of	abstract[107]|event[109]|event[110]	new[107]|new[109]|giv[110]	_	_
13-37	2280-2290	primordial	abstract[107]|event[109]|event[110]|object[111]	new[107]|new[109]|giv[110]|giv[111]	coref	16-13[0_111]
13-38	2291-2300	follicles	abstract[107]|event[109]|event[110]|object[111]	new[107]|new[109]|giv[110]|giv[111]	_	_
13-39	2301-2302	.	_	_	_	_

#Text=For example , Pten and Tsc1 – 2 are negative regulators of this signaling pathway and , in mice , the deletion of these genes from oocytes leads to primordial follicle activation and subsequent early follicular depletion .
14-1	2303-2306	For	_	_	_	_
14-2	2307-2314	example	_	_	_	_
14-3	2315-2316	,	_	_	_	_
14-4	2317-2321	Pten	abstract	giv	_	_
14-5	2322-2325	and	_	_	_	_
14-6	2326-2330	Tsc1	abstract[113]	new[113]	coref	14-10[115_113]
14-7	2331-2332	–	abstract[113]	new[113]	_	_
14-8	2333-2334	2	abstract[113]|quantity	new[113]|giv	_	_
14-9	2335-2338	are	_	_	_	_
14-10	2339-2347	negative	abstract[115]	giv[115]	_	_
14-11	2348-2358	regulators	abstract[115]	giv[115]	_	_
14-12	2359-2361	of	abstract[115]	giv[115]	_	_
14-13	2362-2366	this	abstract[115]|place[117]	giv[115]|giv[117]	coref	16-18[144_117]
14-14	2367-2376	signaling	abstract[115]|abstract|place[117]	giv[115]|new|giv[117]	coref	16-20
14-15	2377-2384	pathway	abstract[115]|place[117]	giv[115]|giv[117]	_	_
14-16	2385-2388	and	_	_	_	_
14-17	2389-2390	,	_	_	_	_
14-18	2391-2393	in	_	_	_	_
14-19	2394-2398	mice	animal	new	_	_
14-20	2399-2400	,	_	_	_	_
14-21	2401-2404	the	event[119]	new[119]	_	_
14-22	2405-2413	deletion	event[119]	new[119]	_	_
14-23	2414-2416	of	event[119]	new[119]	_	_
14-24	2417-2422	these	event[119]|abstract[120]	new[119]|new[120]	_	_
14-25	2423-2428	genes	event[119]|abstract[120]	new[119]|new[120]	_	_
14-26	2429-2433	from	event[119]|abstract[120]	new[119]|new[120]	_	_
14-27	2434-2441	oocytes	event[119]|abstract[120]|object	new[119]|new[120]|giv	coref	16-9[138_0]
14-28	2442-2447	leads	_	_	_	_
14-29	2448-2450	to	_	_	_	_
14-30	2451-2461	primordial	event[123]	giv[123]	coref	15-22[134_123]
14-31	2462-2470	follicle	animal|event[123]	giv|giv[123]	coref	15-23
14-32	2471-2481	activation	event[123]	giv[123]	_	_
14-33	2482-2485	and	_	_	_	_
14-34	2486-2496	subsequent	event[125]	new[125]	_	_
14-35	2497-2502	early	event[125]	new[125]	_	_
14-36	2503-2513	follicular	abstract|event[125]	giv|new[125]	coref	22-26
14-37	2514-2523	depletion	event[125]	new[125]	_	_
14-38	2524-2525	.	_	_	_	_

#Text=In these models , mTOR activity is accelerated within the oocyte , highlighting the critical role of this serine/threonine kinase in primordial follicle activation .
15-1	2526-2528	In	_	_	_	_
15-2	2529-2534	these	abstract[126]	giv[126]	_	_
15-3	2535-2541	models	abstract[126]	giv[126]	_	_
15-4	2542-2543	,	_	_	_	_
15-5	2544-2548	mTOR	place|abstract[128]	giv|new[128]	_	_
15-6	2549-2557	activity	abstract[128]	new[128]	_	_
15-7	2558-2560	is	_	_	_	_
15-8	2561-2572	accelerated	_	_	_	_
15-9	2573-2579	within	_	_	_	_
15-10	2580-2583	the	object[129]	new[129]	coref	19-11[0_129]
15-11	2584-2590	oocyte	object[129]	new[129]	_	_
15-12	2591-2592	,	_	_	_	_
15-13	2593-2605	highlighting	_	_	_	_
15-14	2606-2609	the	abstract[130]	new[130]	coref	21-22[190_130]
15-15	2610-2618	critical	abstract[130]	new[130]	_	_
15-16	2619-2623	role	abstract[130]	new[130]	_	_
15-17	2624-2626	of	abstract[130]	new[130]	_	_
15-18	2627-2631	this	abstract[130]|abstract[132]	new[130]|new[132]	_	_
15-19	2632-2648	serine/threonine	abstract[130]|substance|abstract[132]	new[130]|new|new[132]	_	_
15-20	2649-2655	kinase	abstract[130]|abstract[132]	new[130]|new[132]	_	_
15-21	2656-2658	in	abstract[130]|abstract[132]	new[130]|new[132]	_	_
15-22	2659-2669	primordial	abstract[130]|abstract[132]|event[134]	new[130]|new[132]|giv[134]	coref	16-31[146_134]
15-23	2670-2678	follicle	abstract[130]|abstract[132]|animal|event[134]	new[130]|new[132]|giv|giv[134]	coref	20-7
15-24	2679-2689	activation	abstract[130]|abstract[132]|event[134]	new[130]|new[132]|giv[134]	_	_
15-25	2690-2691	.	_	_	_	_

#Text=The transcription factor FoxO3A , mainly expressed in the oocytes of resting follicles , acts downstream of the PI3K signaling pathway and appears to be the main actor involved in follicular activation .
16-1	2692-2695	The	abstract[136]|abstract[137]	new[136]|new[137]	_	_
16-2	2696-2709	transcription	abstract|abstract[136]|abstract[137]	new|new[136]|new[137]	_	_
16-3	2710-2716	factor	abstract[136]|abstract[137]	new[136]|new[137]	_	_
16-4	2717-2723	FoxO3A	abstract[137]	new[137]	_	_
16-5	2724-2725	,	_	_	_	_
16-6	2726-2732	mainly	_	_	_	_
16-7	2733-2742	expressed	_	_	_	_
16-8	2743-2745	in	_	_	_	_
16-9	2746-2749	the	object[138]	giv[138]	_	_
16-10	2750-2757	oocytes	object[138]	giv[138]	_	_
16-11	2758-2760	of	_	_	_	_
16-12	2761-2768	resting	_	_	_	_
16-13	2769-2778	follicles	object	giv	coref	17-9[149_0]
16-14	2779-2780	,	_	_	_	_
16-15	2781-2785	acts	abstract|place[141]	new|new[141]	_	_
16-16	2786-2796	downstream	place[141]	new[141]	_	_
16-17	2797-2799	of	place[141]	new[141]	_	_
16-18	2800-2803	the	place[141]|place[144]	new[141]|giv[144]	_	_
16-19	2804-2808	PI3K	place[141]|abstract|place[144]	new[141]|giv|giv[144]	_	_
16-20	2809-2818	signaling	place[141]|abstract|place[144]	new[141]|giv|giv[144]	coref	17-17[152_0]
16-21	2819-2826	pathway	place[141]|place[144]	new[141]|giv[144]	_	_
16-22	2827-2830	and	_	_	_	_
16-23	2831-2838	appears	_	_	_	_
16-24	2839-2841	to	_	_	_	_
16-25	2842-2844	be	_	_	_	_
16-26	2845-2848	the	abstract[145]	new[145]	_	_
16-27	2849-2853	main	abstract[145]	new[145]	_	_
16-28	2854-2859	actor	abstract[145]	new[145]	_	_
16-29	2860-2868	involved	_	_	_	_
16-30	2869-2871	in	_	_	_	_
16-31	2872-2882	follicular	event[146]	giv[146]	coref	22-9[192_146]
16-32	2883-2893	activation	event[146]	giv[146]	_	_
16-33	2894-2895	.	_	_	_	_

#Text=At the same time , the survival of primordial follicles is maintained by other mechanisms involving PDK1 signaling , rpS6 .
17-1	2896-2898	At	_	_	_	_
17-2	2899-2902	the	time[147]	giv[147]	_	_
17-3	2903-2907	same	time[147]	giv[147]	_	_
17-4	2908-2912	time	time[147]	giv[147]	_	_
17-5	2913-2914	,	_	_	_	_
17-6	2915-2918	the	event[148]	new[148]	coref	20-2[174_148]
17-7	2919-2927	survival	event[148]	new[148]	_	_
17-8	2928-2930	of	event[148]	new[148]	_	_
17-9	2931-2941	primordial	event[148]|object[149]	new[148]|giv[149]	coref	18-19[160_149]
17-10	2942-2951	follicles	event[148]|object[149]	new[148]|giv[149]	_	_
17-11	2952-2954	is	_	_	_	_
17-12	2955-2965	maintained	_	_	_	_
17-13	2966-2968	by	_	_	_	_
17-14	2969-2974	other	abstract[150]	giv[150]	coref	23-4[202_150]
17-15	2975-2985	mechanisms	abstract[150]	giv[150]	_	_
17-16	2986-2995	involving	abstract[150]	giv[150]	_	_
17-17	2996-3000	PDK1	abstract[150]|abstract|abstract[152]	giv[150]|new|giv[152]	_	_
17-18	3001-3010	signaling	abstract[150]|abstract[152]	giv[150]|giv[152]	_	_
17-19	3011-3012	,	abstract[150]|abstract[152]	giv[150]|giv[152]	_	_
17-20	3013-3017	rpS6	abstract[150]|abstract[152]	giv[150]|giv[152]	_	_
17-21	3018-3019	.	_	_	_	_

#Text=Several studies have suggested the involvement of the autophagy process in the regulation of the ovarian reserve of primordial follicles .
18-1	3020-3027	Several	abstract[153]	giv[153]	_	_
18-2	3028-3035	studies	abstract[153]	giv[153]	_	_
18-3	3036-3040	have	_	_	_	_
18-4	3041-3050	suggested	_	_	_	_
18-5	3051-3054	the	abstract[154]	new[154]	_	_
18-6	3055-3066	involvement	abstract[154]	new[154]	_	_
18-7	3067-3069	of	abstract[154]	new[154]	_	_
18-8	3070-3073	the	abstract[154]|event[156]	new[154]|giv[156]	coref	22-31[199_156]
18-9	3074-3083	autophagy	abstract[154]|abstract|event[156]	new[154]|new|giv[156]	coref	19-4
18-10	3084-3091	process	abstract[154]|event[156]	new[154]|giv[156]	_	_
18-11	3092-3094	in	abstract[154]	new[154]	_	_
18-12	3095-3098	the	abstract[154]|abstract[157]	new[154]|giv[157]	_	_
18-13	3099-3109	regulation	abstract[154]|abstract[157]	new[154]|giv[157]	_	_
18-14	3110-3112	of	abstract[154]|abstract[157]	new[154]|giv[157]	_	_
18-15	3113-3116	the	abstract[154]|abstract[157]|place[159]	new[154]|giv[157]|giv[159]	coref	23-14[205_159]
18-16	3117-3124	ovarian	abstract[154]|abstract[157]|person|place[159]	new[154]|giv[157]|giv|giv[159]	_	_
18-17	3125-3132	reserve	abstract[154]|abstract[157]|place[159]	new[154]|giv[157]|giv[159]	_	_
18-18	3133-3135	of	abstract[154]|abstract[157]|place[159]	new[154]|giv[157]|giv[159]	_	_
18-19	3136-3146	primordial	abstract[154]|abstract[157]|place[159]|object[160]	new[154]|giv[157]|giv[159]|giv[160]	coref	19-35[171_160]
18-20	3147-3156	follicles	abstract[154]|abstract[157]|place[159]|object[160]	new[154]|giv[157]|giv[159]|giv[160]	_	_
18-21	3157-3158	.	_	_	_	_

#Text=For example , autophagy is implicated in maintaining the primordial oocyte pool in murine newborns , and the induction of autophagy at birth seems to be a crucial step to preserve the stock of primordial follicles .
19-1	3159-3162	For	_	_	_	_
19-2	3163-3170	example	_	_	_	_
19-3	3171-3172	,	_	_	_	_
19-4	3173-3182	autophagy	abstract	giv	coref	19-21
19-5	3183-3185	is	_	_	_	_
19-6	3186-3196	implicated	_	_	_	_
19-7	3197-3199	in	_	_	_	_
19-8	3200-3211	maintaining	_	_	_	_
19-9	3212-3215	the	place[163]	giv[163]	_	_
19-10	3216-3226	primordial	place[163]	giv[163]	_	_
19-11	3227-3233	oocyte	object|place[163]	giv|giv[163]	_	_
19-12	3234-3238	pool	place[163]	giv[163]	_	_
19-13	3239-3241	in	place[163]	giv[163]	_	_
19-14	3242-3248	murine	place[163]|abstract|person[165]	giv[163]|new|new[165]	_	_
19-15	3249-3257	newborns	place[163]|person[165]	giv[163]|new[165]	_	_
19-16	3258-3259	,	_	_	_	_
19-17	3260-3263	and	_	_	_	_
19-18	3264-3267	the	event[166]	new[166]	_	_
19-19	3268-3277	induction	event[166]	new[166]	_	_
19-20	3278-3280	of	event[166]	new[166]	_	_
19-21	3281-3290	autophagy	event[166]|abstract	new[166]|giv	_	_
19-22	3291-3293	at	event[166]	new[166]	_	_
19-23	3294-3299	birth	event[166]|event	new[166]|new	_	_
19-24	3300-3305	seems	_	_	_	_
19-25	3306-3308	to	_	_	_	_
19-26	3309-3311	be	_	_	_	_
19-27	3312-3313	a	event[169]	new[169]	_	_
19-28	3314-3321	crucial	event[169]	new[169]	_	_
19-29	3322-3326	step	event[169]	new[169]	_	_
19-30	3327-3329	to	_	_	_	_
19-31	3330-3338	preserve	_	_	_	_
19-32	3339-3342	the	object[170]	new[170]	_	_
19-33	3343-3348	stock	object[170]	new[170]	_	_
19-34	3349-3351	of	object[170]	new[170]	_	_
19-35	3352-3362	primordial	object[170]|object[171]	new[170]|giv[171]	_	_
19-36	3363-3372	follicles	object[170]|object[171]	new[170]|giv[171]	_	_
19-37	3373-3374	.	_	_	_	_

#Text=In the same manner , primordial follicle survival or apoptosis results from a balance between the expression of survival ( antiapoptotic ) and proapoptotic factors .
20-1	3375-3377	In	_	_	_	_
20-2	3378-3381	the	abstract[172]|event[174]|event[175]	giv[172]|giv[174]|giv[175]	coref	20-19[0_174]
20-3	3382-3386	same	abstract[172]|event[174]|event[175]	giv[172]|giv[174]|giv[175]	_	_
20-4	3387-3393	manner	abstract[172]|event[174]|event[175]	giv[172]|giv[174]|giv[175]	_	_
20-5	3394-3395	,	event[174]|event[175]	giv[174]|giv[175]	_	_
20-6	3396-3406	primordial	event[174]|event[175]	giv[174]|giv[175]	_	_
20-7	3407-3415	follicle	animal|event[174]|event[175]	giv|giv[174]|giv[175]	_	_
20-8	3416-3424	survival	event[174]|event[175]	giv[174]|giv[175]	_	_
20-9	3425-3427	or	event[175]	giv[175]	_	_
20-10	3428-3437	apoptosis	event[175]|event|abstract[177]	giv[175]|new|new[177]	_	_
20-11	3438-3445	results	event[175]|abstract[177]	giv[175]|new[177]	_	_
20-12	3446-3450	from	event[175]|abstract[177]	giv[175]|new[177]	_	_
20-13	3451-3452	a	event[175]|abstract[177]|abstract[178]	giv[175]|new[177]|giv[178]	_	_
20-14	3453-3460	balance	event[175]|abstract[177]|abstract[178]	giv[175]|new[177]|giv[178]	_	_
20-15	3461-3468	between	event[175]|abstract[177]|abstract[178]	giv[175]|new[177]|giv[178]	_	_
20-16	3469-3472	the	event[175]|abstract[177]|abstract[178]|abstract[179]	giv[175]|new[177]|giv[178]|new[179]	_	_
20-17	3473-3483	expression	event[175]|abstract[177]|abstract[178]|abstract[179]	giv[175]|new[177]|giv[178]|new[179]	_	_
20-18	3484-3486	of	event[175]|abstract[177]|abstract[178]|abstract[179]	giv[175]|new[177]|giv[178]|new[179]	_	_
20-19	3487-3495	survival	event[175]|abstract[177]|abstract[178]|abstract[179]|event	giv[175]|new[177]|giv[178]|new[179]|giv	_	_
20-20	3496-3497	(	_	_	_	_
20-21	3498-3511	antiapoptotic	substance	new	_	_
20-22	3512-3513	)	_	_	_	_
20-23	3514-3517	and	_	_	_	_
20-24	3518-3530	proapoptotic	abstract[182]	giv[182]	coref	21-2[183_182]
20-25	3531-3538	factors	abstract[182]	giv[182]	_	_
20-26	3539-3540	.	_	_	_	_

#Text=Among these factors , the proteins B-cell lymphoma 2 ( Bcl-2 ) and Bcl-2-associated X protein ( BAX ) likely play a critical role .
21-1	3541-3546	Among	_	_	_	_
21-2	3547-3552	these	abstract[183]	giv[183]	_	_
21-3	3553-3560	factors	abstract[183]	giv[183]	_	_
21-4	3561-3562	,	_	_	_	_
21-5	3563-3566	the	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-6	3567-3575	proteins	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-7	3576-3582	B-cell	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-8	3583-3591	lymphoma	substance[184]|abstract[185]|abstract	new[184]|new[185]|new	_	_
21-9	3592-3593	2	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-10	3594-3595	(	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-11	3596-3601	Bcl-2	substance[184]|abstract[185]|time	new[184]|new[185]|new	_	_
21-12	3602-3603	)	substance[184]|abstract[185]	new[184]|new[185]	_	_
21-13	3604-3607	and	abstract[185]	new[185]	_	_
21-14	3608-3624	Bcl-2-associated	abstract[185]|substance[188]	new[185]|giv[188]	_	_
21-15	3625-3626	X	abstract[185]|substance[188]	new[185]|giv[188]	_	_
21-16	3627-3634	protein	abstract[185]|substance[188]	new[185]|giv[188]	_	_
21-17	3635-3636	(	_	_	_	_
21-18	3637-3640	BAX	object	new	_	_
21-19	3641-3642	)	_	_	_	_
21-20	3643-3649	likely	_	_	_	_
21-21	3650-3654	play	_	_	_	_
21-22	3655-3656	a	abstract[190]	giv[190]	_	_
21-23	3657-3665	critical	abstract[190]	giv[190]	_	_
21-24	3666-3670	role	abstract[190]	giv[190]	_	_
21-25	3671-3672	.	_	_	_	_

#Text=Thus , a synergistic and coordinated suppression of follicular activation , provided by multiple inhibitory and activator molecules , is necessary to preserve the primordial follicular stockpile in association with the process maintaining dormancy .
22-1	3673-3677	Thus	_	_	_	_
22-2	3678-3679	,	_	_	_	_
22-3	3680-3681	a	abstract[191]	new[191]	_	_
22-4	3682-3693	synergistic	abstract[191]	new[191]	_	_
22-5	3694-3697	and	abstract[191]	new[191]	_	_
22-6	3698-3709	coordinated	abstract[191]	new[191]	_	_
22-7	3710-3721	suppression	abstract[191]	new[191]	_	_
22-8	3722-3724	of	abstract[191]	new[191]	_	_
22-9	3725-3735	follicular	abstract[191]|event[192]	new[191]|giv[192]	_	_
22-10	3736-3746	activation	abstract[191]|event[192]	new[191]|giv[192]	_	_
22-11	3747-3748	,	_	_	_	_
22-12	3749-3757	provided	_	_	_	_
22-13	3758-3760	by	_	_	_	_
22-14	3761-3769	multiple	abstract[193]|abstract[194]	giv[193]|giv[194]	_	_
22-15	3770-3780	inhibitory	abstract[193]|abstract[194]	giv[193]|giv[194]	_	_
22-16	3781-3784	and	abstract[194]	giv[194]	_	_
22-17	3785-3794	activator	abstract[194]|substance[195]	giv[194]|giv[195]	_	_
22-18	3795-3804	molecules	abstract[194]|substance[195]	giv[194]|giv[195]	_	_
22-19	3805-3806	,	_	_	_	_
22-20	3807-3809	is	_	_	_	_
22-21	3810-3819	necessary	_	_	_	_
22-22	3820-3822	to	_	_	_	_
22-23	3823-3831	preserve	_	_	_	_
22-24	3832-3835	the	object[197]	new[197]	_	_
22-25	3836-3846	primordial	object[197]	new[197]	_	_
22-26	3847-3857	follicular	abstract|object[197]	giv|new[197]	coref	23-15
22-27	3858-3867	stockpile	object[197]	new[197]	_	_
22-28	3868-3870	in	_	_	_	_
22-29	3871-3882	association	abstract[198]	new[198]	_	_
22-30	3883-3887	with	abstract[198]	new[198]	_	_
22-31	3888-3891	the	abstract[198]|event[199]	new[198]|giv[199]	_	_
22-32	3892-3899	process	abstract[198]|event[199]	new[198]|giv[199]	_	_
22-33	3900-3911	maintaining	_	_	_	_
22-34	3912-3920	dormancy	event	new	_	_
22-35	3921-3922	.	_	_	_	_

#Text=Any disorder in these complex mechanisms can lead to a premature loss of the follicular reserve .
23-1	3923-3926	Any	abstract[201]	new[201]	_	_
23-2	3927-3935	disorder	abstract[201]	new[201]	_	_
23-3	3936-3938	in	abstract[201]	new[201]	_	_
23-4	3939-3944	these	abstract[201]|abstract[202]	new[201]|giv[202]	_	_
23-5	3945-3952	complex	abstract[201]|abstract[202]	new[201]|giv[202]	_	_
23-6	3953-3963	mechanisms	abstract[201]|abstract[202]	new[201]|giv[202]	_	_
23-7	3964-3967	can	_	_	_	_
23-8	3968-3972	lead	_	_	_	_
23-9	3973-3975	to	_	_	_	_
23-10	3976-3977	a	event[203]	new[203]	_	_
23-11	3978-3987	premature	event[203]	new[203]	_	_
23-12	3988-3992	loss	event[203]	new[203]	_	_
23-13	3993-3995	of	event[203]	new[203]	_	_
23-14	3996-3999	the	event[203]|place[205]	new[203]|giv[205]	_	_
23-15	4000-4010	follicular	event[203]|abstract|place[205]	new[203]|giv|giv[205]	_	_
23-16	4011-4018	reserve	event[203]|place[205]	new[203]|giv[205]	_	_
23-17	4019-4020	.	_	_	_	_
